{
    "id": "nclex_ngn_trend_fes_001",
    "itemType": "standalone_trend",
    "question": "The nurse reviews the client's electronic health record (EHR). The client is scheduled to receive enoxaparin 40 mg subcutaneously at 10:00. Based on the trends in the client's data, which action is most appropriate for the nurse to take?",
    "options": [
        {
            "id": "opt_03",
            "label": "C",
            "text": "Increase the nasal cannula to 6 L/min and reassess oxygen saturation in 15 minutes."
        },
        {
            "id": "opt_02",
            "label": "B",
            "text": "Administer the scheduled enoxaparin as ordered for VTE prophylaxis."
        },
        {
            "id": "opt_01",
            "label": "A",
            "text": "Withhold the scheduled enoxaparin and activate the Rapid Response Team (RRT)."
        },
        {
            "id": "opt_04",
            "label": "D",
            "text": "Administer the PRN lorazepam for agitation and reorient the client."
        }
    ],
    "correctAnswerId": "opt_01",
    "rationale": {
        "correct": "The client's presentation is a textbook example of Fat Embolism Syndrome (FES), a life-threatening complication of a long bone fracture. The clinical picture includes the classic triad: respiratory distress (tachycardia, tachypnea, severe hypoxemia refractory to supplemental oxygen), neurological changes (confusion, restlessness), and a petechial rash. The progressive thrombocytopenia and CXR findings of bilateral infiltrates further confirm this diagnosis. Administering an anticoagulant (enoxaparin) is contraindicated in a client with acute neurological decline and thrombocytopenia due to the high risk of precipitating or worsening an intracerebral hemorrhage. The client is unstable and requires immediate escalation of care. Therefore, the nurse must withhold the medication (a 'safety stop') and activate the RRT for immediate life-saving interventions.",
        "incorrect": "The incorrect options represent common but dangerous errors. Administering the enoxaparin ignores critical contraindications. Increasing the oxygen via nasal cannula is an inadequate response to severe, refractory hypoxemia and delays definitive airway management. Administering a sedative like lorazepam is extremely dangerous as it will suppress the client's respiratory drive and mask further neurological deterioration, when the root cause of the agitation is cerebral hypoxia.",
        "answerBreakdown": [
            {
                "label": "A",
                "content": "Withhold the scheduled enoxaparin and activate the Rapid Response Team (RRT).",
                "isCorrect": true,
                "justification": "This is the correct 'SAFETY STOP' action. The client's rapid deterioration with respiratory failure, neurological changes, and thrombocytopenia strongly indicates FES. Administering an anticoagulant in this context is unsafe due to the risk of intracranial bleeding. Activating the RRT brings immediate critical care expertise to the bedside to manage impending respiratory and circulatory collapse."
            },
            {
                "label": "B",
                "content": "Administer the scheduled enoxaparin as ordered for VTE prophylaxis.",
                "isCorrect": false,
                "justification": "This action is extremely dangerous. While VTE prophylaxis is standard for orthopedic clients, the client's acute neurological deterioration and falling platelet count are strong contraindications. Fat emboli can cause hemorrhagic cerebral infarcts, and administering an anticoagulant could be catastrophic."
            },
            {
                "label": "C",
                "content": "Increase the nasal cannula to 6 L/min and reassess oxygen saturation in 15 minutes.",
                "isCorrect": false,
                "justification": "This action is inadequate and delays definitive care. The client's oxygen saturation of 86% on 4L NC indicates severe, refractory hypoxemia consistent with ARDS secondary to FES. A simple titration of the nasal cannula will not resolve the underlying shunt physiology. The client requires a higher level of respiratory support (e.g., non-rebreather mask, high-flow nasal cannula, or intubation) and immediate medical intervention, which is initiated by activating the RRT, not by waiting 15 minutes."
            },
            {
                "label": "D",
                "content": "Administer the PRN lorazepam for agitation and reorient the client.",
                "isCorrect": false,
                "justification": "This action is life-threatening. The client's restlessness and confusion are cardinal signs of cerebral hypoxia, not primary anxiety. Administering a benzodiazepine will suppress the respiratory drive, worsen hypoxemia and hypercapnia, and mask further neurological decline, potentially leading to respiratory arrest."
            }
        ]
    },
    "pedagogy": {
        "bloomLevel": "Analyzing",
        "cjmmStep": "Take Action",
        "nclexCategory": "Management of Care",
        "nclexSubcategory": "Safety and Infection Control",
        "difficulty": "Level 5 (Highly Discriminating)",
        "topicTags": [
            "Fat Embolism Syndrome",
            "Postoperative Complications",
            "Respiratory Failure",
            "Patient Safety",
            "Medication Contraindication",
            "Trend Analysis"
        ]
    },
    "exhibits": [
        {
            "id": "exhibit_nurses_notes",
            "type": "nurses_notes",
            "title": "Nurses' Notes",
            "notes": [
                {
                    "timestamp": "Day 2, 07:30",
                    "author": "RN",
                    "note": "Client is awake, alert, and oriented x3. Reports right femur pain as 5/10. Medicated with IV morphine with good effect. Surgical dressing is clean, dry, and intact. Toes are warm with capillary refill <3 seconds."
                },
                {
                    "timestamp": "Day 2, 09:00",
                    "author": "RN",
                    "note": "Client seems restless, picking at bedsheets. States, 'I feel like I can't catch my breath.' Alert but oriented to person only. Provider notified of restlessness and increased work of breathing. Oxygen applied via nasal cannula at 2 L/min."
                },
                {
                    "timestamp": "Day 2, 09:45",
                    "author": "RN",
                    "note": "Client increasingly confused and agitated. Does not recognize family at bedside. Appears dyspneic even with oxygen increased to 4 L/min. Noted a faint, non-blanching pinpoint rash across the upper chest and in axillae."
                }
            ]
        },
        {
            "id": "exhibit_vitals",
            "type": "vitals_trend",
            "title": "Vital Signs",
            "data": [
                {
                    "timestamp": "Day 2, 07:30",
                    "values": {
                        "HR": "88 bpm",
                        "BP": "124/78 mmHg",
                        "RR": "16/min",
                        "Temp": "37.2°C (99.0°F)",
                        "SpO2": "98% on Room Air"
                    }
                },
                {
                    "timestamp": "Day 2, 09:00",
                    "values": {
                        "HR": "115 bpm",
                        "BP": "120/75 mmHg",
                        "RR": "28/min",
                        "Temp": "38.1°C (100.6°F)",
                        "SpO2": "91% on 2L NC"
                    }
                },
                {
                    "timestamp": "Day 2, 09:45",
                    "values": {
                        "HR": "132 bpm",
                        "BP": "105/60 mmHg",
                        "RR": "34/min",
                        "Temp": "38.5°C (101.3°F)",
                        "SpO2": "86% on 4L NC"
                    }
                }
            ]
        },
        {
            "id": "exhibit_labs_diagnostics",
            "type": "labs_and_diagnostics",
            "title": "Labs & Diagnostics",
            "data": [
                {
                    "category": "Laboratory Results",
                    "timestamp": "Day 2, 09:15",
                    "tests": [
                        {
                            "name": "Hemoglobin",
                            "value": "12.5 g/dL",
                            "reference": "13.5-17.5 g/dL"
                        },
                        {
                            "name": "Platelets",
                            "value": "110,000/mm³",
                            "reference": "150,000-450,000/mm³"
                        },
                        {
                            "name": "Arterial Blood Gas (on 2L NC)",
                            "value": "pH 7.49 | PaCO₂ 31 mmHg | PaO₂ 58 mmHg | HCO₃ 23 mEq/L"
                        }
                    ]
                },
                {
                    "category": "Radiology",
                    "timestamp": "Day 2, 09:30",
                    "tests": [
                        {
                            "name": "Chest X-Ray (Portable)",
                            "report": "Findings: Bilateral, diffuse pulmonary infiltrates noted. No evidence of cardiomegaly or pleural effusion. Impression: Findings consistent with acute respiratory distress syndrome (ARDS)."
                        }
                    ]
                }
            ]
        },
        {
            "id": "exhibit_mar",
            "type": "mar",
            "title": "Medication Administration Record",
            "patientInfo": {
                "name": "Client, John",
                "age": "22 years",
                "allergies": "No Known Allergies",
                "diagnosis": "Right Femur Fracture status-post ORIF"
            },
            "medications": [
                {
                    "name": "Enoxaparin",
                    "dose": "40 mg",
                    "route": "Subcutaneous",
                    "frequency": "Daily",
                    "timeDue": "10:00",
                    "notes": "For VTE Prophylaxis"
                },
                {
                    "name": "Lorazepam",
                    "dose": "1 mg",
                    "route": "IV",
                    "frequency": "PRN q4h",
                    "timeDue": "PRN",
                    "notes": "For anxiety or agitation"
                },
                {
                    "name": "Morphine Sulfate",
                    "dose": "2 mg",
                    "route": "IV",
                    "frequency": "PRN q2h",
                    "timeDue": "PRN",
                    "notes": "For moderate to severe pain"
                }
            ]
        }
    ],
    "caseInfo": {
        "patient": {
            "age": "22",
            "gender": "Male",
            "background": "The client is a 22-year-old male who sustained a closed right femur fracture in a motor vehicle collision yesterday. He underwent an open reduction and internal fixation (ORIF) 18 hours ago. He has no significant past medical history."
        }
    }
}